Cognitive Drug Research, Ltd (CDR) provides automated cognitive assessments for clinical trials. The company's gold standard automated cognition assessment system has been used in over 1,000 sites and 500 clinical trials, across all phases of drug development and in a vast array of indications. CDR's solution combines the most accurate testing technology available with unrivaled expert analysis and interpretation of results. The CDR system is highly sensitive to alterations in cognitive function produced by pharmaceutical and nutraceutical compounds, ageing, and disease. The system is supported by the largest known database of cognitive performance, is available in over 45 languages, is GCP and FDA 21 CFR Part 11 compliant, and is the subject of over 170 peer-reviewed papers and chapters.
|
